Literature DB >> 17962934

Reaction and strain engineering for improved stereo-selective whole-cell reduction of a bicyclic diketone.

Ted Johanson1, Magnus Carlquist, Cecilia Olsson, Andreas Rudolf, Torbjörn Frejd, Marie F Gorwa-Grauslund.   

Abstract

Reduction of bicyclo[2.2.2]octane-2,6-dione to (1R, 4S, 6S)-6-hydroxy-bicyclo[2.2.2]octane-2-one by whole cells of Saccharomyces cerevisiae was improved using an engineered recombinant strain and process design. The substrate inhibition followed a Han-Levenspiel model showing an effective concentration window between 12 and 22 g/l, in which the activity was kept above 95%. Yeast growth stage, substrate concentration and a stable pH were shown to be important parameters for effective conversion. The over-expression of the reductase gene YDR368w significantly improved diastereoselectivity compared to previously reported results. Using strain TMB4110 expressing YDR368w in batch reduction with pH control, complete conversion of 40 g/l (290 mM) substrate was achieved with 97% diastereomeric excess (de) and >99 enantiomeric excess (ee), allowing isolation of the optically pure ketoalcohol in 84% yield.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962934     DOI: 10.1007/s00253-007-1240-1

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

1.  Increased availability of NADH in metabolically engineered baker's yeast improves transaminase-oxidoreductase coupled asymmetric whole-cell bioconversion.

Authors:  Jan Dines Knudsen; Cecilia Hägglöf; Nora Weber; Magnus Carlquist
Journal:  Microb Cell Fact       Date:  2016-02-15       Impact factor: 5.328

2.  Yeast cell factories for fine chemical and API production.

Authors:  Beate Pscheidt; Anton Glieder
Journal:  Microb Cell Fact       Date:  2008-08-07       Impact factor: 5.328

3.  Exploiting cell metabolism for biocatalytic whole-cell transamination by recombinant Saccharomyces cerevisiae.

Authors:  Nora Weber; Marie Gorwa-Grauslund; Magnus Carlquist
Journal:  Appl Microbiol Biotechnol       Date:  2014-02-21       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.